PatternsRadar
Sign in

BPLPHARMABPLPHARMA

NSEASM Stage I
2,312.00INR-89.00 (-3.71%)Close · 20 Nov 2026
—Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1,593 CrMarket cap
—P/E (TTM)
45.6%Delivery

Filings & corporate actions

CSV
Dividend
₹1.00 per share · last 11 Sept 2026
2026
  • 11 SeptdividendDividend · ₹1.00 per share-3.4%

Growth

Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ—
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open2,390.00
Day range2,300.00 – 2,405.90
52-week range—
From 52w high—
RSI (14)65.6
ATR (14)143.68
Volume4.0K
Avg volume (20D)23.5K
Rel volume0.17×
Volatility (1Y)73.6%
Turnover₹92.8L
Traded value (NSE)₹92.8L
VWAP2,348.92
SMA 50 / 2001,838.03 / —
Price band20%

Delivery percentage

Latest · 20 Nov 202645.6%
20-day avg44.1%
1-year avg57.0%
Percentile (own history)27th
Range12.4–97.3%
Sessions67

Over the last 20 sessions BPLPHARMA settled 44.1% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 57.0%, so recent sessions are running 12.9 points lower than usual.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.04%
Dividend, trailing 12M₹1.00
Paid every year for1 yr
Shareholders—
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buynever

Performance returns

1D1W1M3M6M1Y
Price-3.71%+9.02%+30.18%+78.57%——

Valuation

Market cap₹1,593 Cr
Market cap (NSE)₹1,593 Cr
Free-float cap—
P/E (TTM)—
EPS (TTM)—
P/B—
Net margin (TTM)—
Other income / PBT—
ROE—
Debt / equity—
Shares outstanding—
Listed17 Aug 2026

Ownership

Promoter—
Promoter Δ QoQ—
Public—
FII—
DII—
Pledged—

Dividends

since 11 Sept 2026 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹1.00₹1.00
Ex-dateRecord dateDeclaredAdjusted
11 Sept 2026—₹1.00₹1.00

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Exchange surveillance

20 Nov 2026
  • Short-term ASM · Stage I · since 19 Nov 2026 — Short-term Additional Surveillance Measure: a sharp move over a few days; a higher margin applies while it lasts.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

BPLPHARMA at a glance

  • BPLPHARMA closed at ₹2,312 on 20 Nov 2026, -3.71% on the day.
  • Delivery was 45.6% of traded quantity on 20 Nov 2026, the 27th percentile of its own 67 sessions with a reading (20-session average 44.1%, 1-year average 57.0%).
  • Market capitalisation is ₹1,593 crore, with no positive trailing earnings for a P/E.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE365Y01019
SeriesEQ
Listed17 Aug 2026
NSE market cap · 17 Nov 2026₹1,522 Cr
Free-float market cap (NSE)₹499 Cr
Shares outstanding (NSE)68.92L
History from17 Aug 2026
Sessions67

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.